Navigation Links
InspireMD Provides Mid-Year Strategic Update
Date:8/16/2011

shipped the initial order for the MGuard™ stent to India.
  • During March and April 2011, InspireMD completed financing transactions totaling $11.1 million, comprised of $10.4 million in cash and $0.7 million worth of loans that were converted into common stock and warrants.

  • Dr. Asher Holzer, Co-Founder of InspireMD and the Company's President, commented, "InspireMD continues to make significant progress in developing, clinically validating and ultimately commercializing our patent-pending mesh net technology. Our presence at the EuroPCR conference in Paris in May was well-received, and the cocktail reception we hosted to celebrate the commencement of the MASTER randomized trial was attended by many industry leaders, demonstrating the significant and growing interest in our technology. We expect data from our MASTER trial, chaired by Dr. Gregg Stone, Director of Cardiovascular Research and Education from Columbia University in New York, in mid-2012, and are confident this study will drive additional adoption of our technology. In addition, we have begun the process of securing approval to sell our stents in the United States, pending approval from the United States Food and Drug Administration (FDA), which is targeted during 2014. We continue to collaborate with the Harvard Clinical Research Institute (HCRI), an international leader in design and conduct of coronary device trials, in order to obtain FDA approval."

    Mr. Ofir Paz, Co-Founder and CEO of InspireMD, commented, "In addition to our focus on the clinical data necessary to advance our efforts, we are simultaneously expanding our sales and marketing efforts in anticipation of the completion of the MASTER trial. This effort includes the recruiting of proven sales and marketing leadership to further grow our global distribution and the expansion of the sales and marketing team with the addition of proven personnel in key regions. In addition, we remain focused on innovation,
    '/>"/>

    SOURCE InspireMD, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. InspireMD Elects Two New Board Members
    2. Sol J. Barer, Ph.D. Joins InspireMD Board of Directors
    3. InspireMD Broadens Global Distribution Network; Signs Distributor for the Russian Federation
    4. InspireMD Announces Year-to-Date 2011 Progress
    5. InspireMD Promotes MGuard™ at the EuroPCR 2011 Exhibition and Conference in Paris This Week
    6. InspireMD Increases Geographic Penetration; MGuard Stent is Now Available in India
    7. InspireMD to Participate in Benchmark Company, LLC 2011 One-On-One Investor Conference
    8. InspireMD to Commence Trading as a Public Company Under Ticker Symbol "NSPR"
    9. InspireMD Boosts MGuard Production Capacity
    10. InspireMD Becomes a Supporting Organization in the Growing Stent for Life Initiative
    11. For the First Time, at EuroPCR, InspireMD Will Provide a Sneak Preview of the Next Generation MGuard Prime(R), a State of the Art Net Protective Cobalt Chromium Stent System
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/31/2015)... 31, 2015  The departments of Drug and Alcohol ... Gaudenzia Concept 90 to raise awareness for International Overdose ... Pennsylvania and help more Pennsylvanians ... recovery through the Building Bridges to Recovery ... every day to a disease that is fully treatable, ...
    (Date:8/31/2015)... Mich. , Aug. 31, 2015  Diplomat Pharmacy, Inc. ... has announced that Phil Hagerman , Chairman & CEO, ... upcoming investor conferences. Mr. Hagerman and Mr. ... Healthcare Conference in Boston on Wednesday, ... Hagerman and Mr. Whelan are also scheduled to participate in ...
    (Date:8/31/2015)... Soligenix, Inc. (OTCQB: SNGX) (Soligenix or ... that address unmet medical needs in the areas ... has completed enrollment of the additional subjects, as ... this year, into the company,s Phase 2 study ... regulator (IDR) and is being evaluated as a ...
    Breaking Medicine Technology:Pennsylvania Departments of Drug & Alcohol Programs and Health Kick-off Second Annual Building Bridges to Recovery Initiative 2Diplomat to Participate in Upcoming Investor Conferences 2Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 2Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 3Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 4Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 5Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 6
    ... 8, 2011 Elsevier Business Intelligence , ... conferences, is hosting Windhover,s 21 st Pharmaceutical Strategic ... in New York, NY. PSA is the only ... a diverse mix of pharma,s top talent. It,s an opportunity ...
    ... Medical, a leading manufacturer of integrated medical imaging display and ... year, Carrot Medical achieved significant growth in sales and an ... of 2011 with record second quarter sales, Carrot surpassed its ... company is now well positioned for the third straight year ...
    Cached Medicine Technology:Biopharma Leaders Discuss Pharma's Future at Pharmaceutical Strategic Alliances in New York 2Biopharma Leaders Discuss Pharma's Future at Pharmaceutical Strategic Alliances in New York 3Carrot Medical Positioned for Third Straight Year of Triple Digit Growth 2
    (Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... ... management, recently opened registration for the company’s second Introduction to Hyperbaric Medicine Course. ... October 15-18, 2015 aboard the Queen Mary Hotel in Long Beach, CA. The ...
    (Date:8/31/2015)... ... August 31, 2015 , ... ... a one-day event geared to patients and family members, medical professionals, and researchers, ... regional mesothelioma experts. The conference is a collaborative effort between the Mesothelioma ...
    (Date:8/31/2015)... , ... August 31, 2015 , ... Patients who thought ... those who are interested in learning more about the procedure beyond the information found ... , Internationally recognized hair transplant surgeon Parsa Mohebi will be on hand to answer ...
    (Date:8/31/2015)... ... August 31, 2015 , ... The Sundance Film Festival ... Tuesday, September 1. , “Alive Inside” shadows a social worker who advocates for the ... “It’s a documentary about bringing music to residents in health care centers who may ...
    (Date:8/31/2015)... ... August 31, 2015 , ... Garden State Urology is ... result of a merger of five of the busiest urology practices in Morris ... more cost-effective and higher quality care than they did individually. Their mission ...
    Breaking Medicine News(10 mins):Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 2Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 3Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 4Health News:New York Experts on Mesothelioma Come Together at Memorial Sloan Kettering Cancer Center 2Health News:New York Experts on Mesothelioma Come Together at Memorial Sloan Kettering Cancer Center 3Health News:Watch a Live Hair Transplant at Parsa Mohebi Hair Restoration’s Open House 2Health News:Public Invited to Dementia Documentary Screening at North Carolina Retirement Community 2Health News:NJ Top Docs Presents, Garden State Urology! 2
    ... is a dramatic shift in attitudes toward circumcision in Swaziland, ... of the practice and one of the highest HIV prevalence ... it is making a sudden comeback in the country since ... practice could reduce the risk of contracting HIV. ...
    ... of the most frequent New Year resolutions is "I'll quit ... find it hard to keep their good // ... Now an initiative undertaken by the Manchester Evening News, a ... resolution. ,The paper has undertaken this ...
    ... high as researchers feel that if mutation of the bird flu ... death world wide as the virus could have the capacity to ... in China from spread to poultry of bird flu virus from ... to bird flu recently in the Sanming City. World Health Organization ...
    ... death sentence. It is the most lethal cancer there is. ... GBM annually in the U.S., half // will ... The treatments include highly invasive surgeries to remove the tumor ... to a very low quality of life. Hence, researchers are ...
    ... University of Michigan’s researchers has revealed that those children who live ... to put on weight. As many as 16% of those belonging ... are reported to be overweight, while in the UK the number ... early 1990s. ,The researchers, led by Julie Lumeng, ...
    ... have one more reason to raise a toast- a formula ... you // can pep-up your spirits and relish ... Coventry University, and author of the formula for Marks & ... popping open a champagne bottle. According to smith, P = ...
    Cached Medicine News:Health News:Men queue up for Circumcision In Swaziland To Prevent HIV/AIDS 2Health News:Radiology advance points way to non-invasive brain cancer treatment 2Health News:Surroundings Have An Effect On Weight 2
    LUMIGAN® is a powerful eye drop medication for lowering IOP. IOP is short for intraocular pressure or eye pressure. LUMIGAN® is the first in a new class of medication....
    ... New REFRESH LIQUIGEL® Lubricant Eye Drops ... with the convenience of a liquid ... protection. Its extra-strength CMC formula provides ... comfort. And with the PURITE® preservative, ...
    Due to its thick formula, REFRESH CELLUVISC Lubricant Eye Drops is ideal for persistent dry eye conditions. REFRESH CELLUVISC provides lasting relief and protection for dry, scratchy eyes....
    ... solution is an anti-infective prescription ... may instruct you to use ... infection caused by bacteria. Bacterial ... the 2 types of eye ...
    Medicine Products: